Infliximab for the treatment of plaque psoriasis
Jennifer S Gall, Robert E KalbState University of New York at Buffalo, School of Medicine and Biomedical Sciences, Department of Dermatology, NY, USAAbstract: Infliximab is a monoclonal antibody that targets tumor necrosis factor-α (TNFα). It is used in the treatment of a...
Saved in:
Main Authors: | Jennifer S Gall, Robert E Kalb |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/36deadb9adb34b80ae04e18b50667003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ustekinumab in the therapy of chronic plaque psoriasis
by: Jenna L O’Neill, et al.
Published: (2009) -
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
by: Santo Raffaele Mercuri, et al.
Published: (2010) -
Infliximab in the treatment of rheumatoid arthritis
by: A Perdriger
Published: (2009) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
by: Matsumoto S, et al.
Published: (2018) -
Infliximab in ulcerative colitis
by: Avi Levin, et al.
Published: (2008)